Norethindrone substituted for megestrol in the treatment of metastatic endometrial carcinoma: Three cases

Megestrol is an effective palliative treatment for endometrial carcinoma. Some persons with progestin-responsive cancer continue on hormonal therapy for months or even years. In persons who respond to megestrol, long term use can cause weight gain and other side effects via activity of the drug at t...

Full description

Bibliographic Details
Main Authors: William L. Read, Sumita Trivedi, Felicia Williams
Format: Article
Language:English
Published: Elsevier 2017-11-01
Series:Gynecologic Oncology Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578917301078

Similar Items